These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9554862

  • 21. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV, Preobrazhenskiĭ DV, Ob ukhova OA.
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract] [Full Text] [Related]

  • 22. [Nephrotoxicity of drugs].
    Paoletti V, Mammarella A, Falaschi R, Labbadia G, Donnarumma L, Musca A.
    Clin Ter; 1995 Jan; 146(1):49-64. PubMed ID: 7705013
    [Abstract] [Full Text] [Related]

  • 23. [Therapy of heart failure with angiotensin converting enzyme inhibitors. Effects on renal function].
    Osterziel KJ, Dietz R, Kübler W.
    Dtsch Med Wochenschr; 1989 Jul 07; 114(27):1082-5. PubMed ID: 2661192
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of nephrotic syndrome in adults].
    Honkanen E.
    Duodecim; 2000 Jul 07; 116(21):2355-63; quiz 2363-4, 2389. PubMed ID: 12053363
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of nephrotic syndrome.
    Arneil GC.
    Turk J Pediatr; 1973 Jan 07; 15(1):52-66. PubMed ID: 4616430
    [No Abstract] [Full Text] [Related]

  • 26. ACE-inhibitors-induced metabolic acidosis in a child with nephrotic syndrome.
    Bruno I, Pennesi M, Marchetti F.
    Pediatr Nephrol; 2003 Dec 07; 18(12):1293-4. PubMed ID: 14579142
    [Abstract] [Full Text] [Related]

  • 27. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP.
    Nephrol Dial Transplant; 1994 Dec 07; 9(3):244-50. PubMed ID: 8052429
    [Abstract] [Full Text] [Related]

  • 28. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome.
    Don BR, Wada L, Kaysen GA, Schambelan M.
    Kidney Int Suppl; 1989 Nov 07; 27():S163-7. PubMed ID: 2561515
    [No Abstract] [Full Text] [Related]

  • 29. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA, Davies RW.
    J Am Soc Nephrol; 1990 Nov 07; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [Abstract] [Full Text] [Related]

  • 30. [Nephrotic syndrome. Physiopathology, diagnosis, development, treatment of lipoid nephrosis].
    Chabannier MH, Modesto A, Orfila C, Suc JM.
    Rev Prat; 1996 Oct 01; 46(15):1907-15. PubMed ID: 8953847
    [No Abstract] [Full Text] [Related]

  • 31. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ, Wetzels JF.
    Ned Tijdschr Geneeskd; 1998 Dec 26; 142(52):2832-8. PubMed ID: 10065257
    [Abstract] [Full Text] [Related]

  • 32. [The combined use of diuretics and drug preparations from other groups].
    Glezer GA.
    Ter Arkh; 1993 Dec 26; 65(8):81-6. PubMed ID: 8105551
    [No Abstract] [Full Text] [Related]

  • 33. [The treatment of acute glomerulonephritis and nephrotic syndrome in childhood].
    Brodehl J.
    Dtsch Med J; 1969 Jul 26; 20(14):441-7. PubMed ID: 4897091
    [No Abstract] [Full Text] [Related]

  • 34. Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.
    Kumar NS, Singh AK, Mishra RN, Prakash J.
    J Assoc Physicians India; 2004 Jun 26; 52():454-8. PubMed ID: 15645954
    [Abstract] [Full Text] [Related]

  • 35. [Nephrotic syndrome: therapeutic possibilities].
    Meesen BP.
    Ned Tijdschr Geneeskd; 1992 May 16; 136(20):992. PubMed ID: 1317511
    [No Abstract] [Full Text] [Related]

  • 36. Overdrugged patients: enough is enough.
    Rapoport D.
    Can Fam Physician; 2002 Nov 16; 48():1764. PubMed ID: 12489240
    [No Abstract] [Full Text] [Related]

  • 37. Angiotensin converting enzyme inhibition in non-diabetic nephropathy with non-nephrotic proteinuria.
    Pennesi M, Torre G.
    Pediatr Nephrol; 2000 May 16; 14(5):438. PubMed ID: 10805476
    [No Abstract] [Full Text] [Related]

  • 38. [Nephrotoxicity of non-steroidal anti-inflammatory agents. Apropos of 6 case reports and review of the literature].
    Collet P, Beaune J, Llorca G.
    Therapie; 1987 May 16; 42(4):379-85. PubMed ID: 3317984
    [No Abstract] [Full Text] [Related]

  • 39. A stepwise approach to the treatment of early onset nephrotic syndrome.
    Licht C, Eifinger F, Gharib M, Offner G, Michalk DV, Querfeld U.
    Pediatr Nephrol; 2000 Oct 16; 14(12):1077-82. PubMed ID: 11045390
    [Abstract] [Full Text] [Related]

  • 40. [Nephrotic syndrome].
    Abe H, Furukawa T, Urabe S, Orita Y.
    Nihon Rinsho; 1971 Nov 16; 29(11):2878-89. PubMed ID: 5168843
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.